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Abstract
Background: Similar to other systems, the endocrine system is affected by aging. Thyroid hormone, the action of
which is affected by many factors, has been shown to be associated with longevity. The most useful marker for the
assessment of thyroid hormone action is TSH level. Although age and gender are believed to modify the pituitary
set point or response to free thyroid hormone concentration, the precise age- and gender-dependent responses to
thyroid hormone have yet to be reported.
Methods: We analyzed the results of 3564 thyroid function tests obtained from patients who received medication
at both out- and inpatient clinics of Shinshu University Hospital. Subjects were from among those with thyroid
function test results in the normal or mildly abnormal range. Based on a log-linear relationship between the
concentrations of FHs and TSH, we established the putative resistance index to assess the relation between serum
FH and TSH levels.
Results: Free thyroid hormone and TSH concentration showed an inverse log-linear relation. In males, there was a
negative relationship between the free T3 resistance index and age. In females, although there were no
relationships between age and FHs, the indices were positively related to age.
Conclusions: These findings indicated that there is a gender-specific response to thyroid hormone with aging.
Although the TSH level is a useful marker for the assessment of peripheral thyroid hormone action, the values
should be interpreted carefully, especially with regard to age- and gender-related differences.
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Introduction
In common with other systems, the endocrine system is
affected by aging. With regard to thyroid hormone, age
modifies the pituitary set point or response to compar-
ably reduced free T4 (FT4) concentrations, resulting in
lesser serum TSH elevation in older individuals [1].
TSH is suppressed in elderly subjects [2]. The decreased
thyroid hormone levels observed in aging are due to
lower TSH concentrations [3]. Centenarians exhibit sig-
nificantly lower TSH levels together with slightly higher
reverse T3 levels than aged controls [4]. In contrast to
several reports on the association between low TSH
level and senescence, heritable longevity has been
reported to be associated with high serum TSH and low
free T4 levels [5]. Exceptional longevity is associated
with raised serum TSH [6,7]. Thus, the relation between
the level of TSH and lifespan is controversial.
TSH concentration is higher in women than in men
[8]. TSH daily profiling demonstrated that TSH secre-
tion depends on age in women only [9]. These reports
suggest that thyroid hormone function, especially TSH
level, may be associated with gender differences.
Both T3 and T4 are often loosely referred to as thyr-
oid hormones, although T3 alone has biological thyro-
mimetic activity at the genomic level. The ratio of
serum FT3 concentration to FT4 concentration, [FT3]/
[FT4] index, is a useful indicator to assess the peripheral
metabolism of thyroid hormone, as the index is affected
by the magnitude of the conversion of FT4 to FT3 or of
the transport of T4 into T3-producing tissues [10].
Serum concentration of thyroid hormone is inversely
related to TSH concentration. Although the serum
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cells, clinical manifestations of thyroid hormone action
are occasionally not related to the serum hormone con-
centration. For example, we observe low FT3 concentra-
tions in patients with severe disorders or infection, i.e.,
low T3 syndrome. Moreover, molecular studies have
strongly suggested that the nuclear action of thyroid
hormone may be affected by numerous factors. MCT8
is a specific transporter of T3 [11]. μ-crystallin is a cyto-
plasmic thyroid hormone binding protein within cells,
which may also affect the action of thyroid hormone
[12]. Phosphodiesterase 8B gene variants are associated
with serum TSH levels and thyroid function [13]. Mole-
cules that affect the transcriptional machinery also alter
the response to thyroid hormone [14]. Taken together,
these clinical and molecular findings suggest that factors
responsible for the action of thyroid hormone except for
thyroid hormone itself are present in vivo. The patho-
physiological alteration may manifest thyroid hormone
resistance, similar to the insulin resistance in diabetic or
obese patients.
Free hormones (FHs) are undoubtedly the strongest
factors that affect the regulation of TSH expression.
There is a log-linear relationship between free thyroxin
and TSH over a wide concentration range [15].
Although the resistance factors affect the regulation of
TSH secretion, these effects may be diminished in the
severe hyper- or hypothyroid state. That is, if the resis-
tance factors exist, these factors may be clearly observed
in euthyroid or moderate hyper- and hypothyroid states.
Based on these speculations, we selected data with
TSH from 0.04 to 9.99 μIU/ml and FT4 from 0.52 to
2.1 ng/dl. We established the putative resistance index
obtained from the serum concentration of thyroid hor-
mone and TSH, and investigated the existence of age-
and gender-related factors that affect thyroid hormone
resistance. In addition, we discuss the physiological




A total of 1026 male and 2538 female (median age 44
years, range 15 - 92 years) subjects were included in this
study. All patients were referred to in- or outpatient
clinics of Shinshu University Hospital from January
2004 to January 2005 due to suspected thyroid disease
or to receive treatment for various thyroid diseases,
including Graves’ disease, autoimmune and non-immu-
nogenic thyroiditis, benign diffuse and nodular goiter,
and thyroid malignancies. This study was approved by
the Ethical Committee of Shinshu University (reference
number 818).
Laboratory methods
Standard laboratory quality evaluation procedures were
routinely employed, and regular participation at inter-
laboratory tests was also part of the quality management
strategy. Inter- and intraassay coefficients of variation
were 2.2 and 0.8% for TSH, 4.5 and 1.8% for FT3, 4.6
and 1.3% for FT4, respectively.
Statistical analysis
For pairs of continuous variables, scatter plots were con-
structed to visually display the respective relations. If
found to be linear with both variables showing a normal
distribution, Pearson’s correlation was computed to sta-
tistically describe the significance, strength, and nature of
the relation using SPSS version 18. In the age distribu-
tion, statistical significance was determined by Kruskal-
Wallis followed by the Games-Howell multiple compari-
son test. P values ≥ 0.05 were considered not significant.
Results
Characteristics of the study population
To select the normal and subnormal regulation of thyroid
hormone and TSH, we omitted data from subjects with
serum TSH concentration ([TSH]) less than 0.04 μIU/ml
and greater than 9.99 μIU/ml. We also omitted data from
those with serum FT4 concentration ([FT4]) less than 6.7
pM (0.52 ng/dl) and greater than 27.0 pM (2.1 ng/dl).
The adopted range was mean ± 2 S.D. as shown in Figure
1a. A total of 735 male and 1721 female subjects were
included in the analysis. The detailed characteristics of
the study population are shown in Table 1.
Organization of a resistance index
A ss h o w ni nF i g u r e1 b ,t h ed a t ai nt h i ss t u d ys h o w e da
log-linear relationship between FT4 and TSH (log[TSH]
= 1.729 - 0.09[FT4], P < 0.001). The linear regression line
also showed a good fit to the data points obtained from
FT3 and log [TSH] (log[TSH] = 0.429 - 0.034[FT3] P =
0.02). We can express the relation between log[TSH] and
the concentration of a free hormone [FH] as follows:
log[TSH] =b− a[FH]

a,b; any positive number

To simplify the equation, we set a = 1:
log[TSH] =b− [FH]
We would express a conventional resistance index
(Rconv) as follows:
Rconv = [FH] +l o g[TSH]
To be equivalent to the strength of each factor, such
as [FH] and log[TSH], we converted each factor to a
value ranging from 0 to 1 as follows:
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+( l o g[TSH] − log[TSH]min)/( l o g [TSH]max − log[TSH]min)
In this study,
[FT3]max = 9.97pM, [FT3]min = 0.84pM, [FT4]max = 26.93pM, [FT4]min = 6.83pM,
log[TSH]max =2 . 3l o g [TSH]min = −3.22.
Thus, the T3 resistance index (ResT3) and T4 resis-
tance index (ResT4) were defined as follows:
ResT3 = ([FT3] − 0.84)/9.13 +

log[TSH] +3 . 2 2

/5.52
ResT4 = ([FT4] − 6.83)/20.1 +

log[TSH] +3 . 2 2

/5.52
Concentration of free thyroid hormone and resistance
indices were decreased with aging in males
We performed linear regression analysis between age and
concentrations of free T3, T4, and TSH, values of log
[TSH], both resistance indices and the [FT3]/[FT4] index.
In males, the concentrations of FHs were negatively
related to aging, while the TSH level was not (Figure 2a, b
and 2c, Table 2). Both resistance indices decreased signifi-
cantly with age (Figure 2d and 2e). The [FT3]/[FT4] index
decreased significantly (Figure 2f, Table 2).
In females, the free thyroid hormone concentration was
not altered by aging, but the TSH level increased in an
age-dependent manner
We plotted the values of a series of thyroid hormone
indices vs.a g ei nf e m a l e s .T h e r ew e r en or e l a t i o n s h i p s
between the concentrations of both FHs and age (Figure
3a and 3b, Table 2). TSH level was significantly
Figure 1 Frequency distribution of serum free T4 concentration and log-linear relationship of the serum concentration between of
free T4 and of TSH in this study. (a) Frequency distribution of serum free T4 concentration. The gray column represents 2519 samples with
TSH ranging from 0.04 to 9.99 selected from the total of 3564 samples. (b) The relationship between [FT4] and log[TSH]. The line represents the
linear regression fitted to the data points using SPSS software.
Table 1 Clinical characteristics of the study population
Characteristics male female
n = 735 n = 1721
Age - years
Mean ± SD 46.94 ± 16.24 44.05 ± 17.0
Range 15 - 84 15 - 82
Free T3 - pM
Mean ± SD 5.91 ± 1.7 5.36 ± 1.55
Range 1.38 - 9.97 0.84 - 9.85
Free T4 - pM
Mean ± SD 16.85 ± 3.81 16.3 ± 3.51
Range 6.96 - 26.9 6.83 - 26.9
TSH - μIU/ml
Mean ± SD 2.44 ± 2.14 1.99 ± 1.91
Range 0.04 - 9.99 0.04 - 9.95
log [TSH]
Mean ± SD 0.464 ± 1.06 0.142 ± 1.21
Range -3.21 - 2.30 -3.21 - 2.30
ResT3
Mean ± SD 1.22 ± 0.26 1.10 ± 0.27
Range 0.27 - 1.90 0.24 - 1.91
ResT4
Mean ± SD 1.16 ± 0.25 1.08 ± 0.23
Range 0.05 - 1.78 0.16 - 1.93
[FT3]/[FT4]
Mean ± SD 0.37 ± 0.13 0.34 ± 0.12
Range 0.11 - 0.84 0.06 - 0.98
Res: resistance index
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with age (Figure 3d and 3e). The [FT3]/[FT4] index did
not change significantly with age (Figure 3f).
Gender-specific differences in resistance indices in the
age distribution
According to our mathematical model, the age-dependent
distribution revealed a specific pattern in both male and
female subjects. As shown in Figure 4a, the mean values of
the T3 index decreased in the age group from 15 - 24 to
25 - 34, and then increased slightly in the 25 - 64 age
groups in males. The value decreased again over the 55 -
64 age group in males. The mean values of the T3 index
increased gradually between the 35 - 44 and 55 - 64 age
groups in females. Although there was no statistical signif-
icance, the values were decreased in females over 65.
On the other hand, the mean values of the T4 index
were reduced in males between 15 - 24 and 25 - 34
(Figure 4b). The values were constant over the 25 - 34
age group. In females, the mean values of the T4 index
initially decreased between 15 - 24 and 25 - 34. The
values increased gradually over the 25 - 34 age group
except in the 65 - 74 and 75 - 84 age groups. The mean
values of the [FT3]/[FT4] index decreased in males in
t h e6 5-7 4a n d7 5-8 4a g eg r o u p s ,w h i l et h ev a l u e
remained constant in females (Figure 4c). The statistical
differences were shown in Table 3.
Discussion
In this study, we selected the cases with normal or sub-
normal thyroid function. Despite the narrow range of
the study population, an inverse log-linear relation
Figure 2 The relationship between age versus the concentration of FT3 (a), FT4 (b), log[TSH] (c), ResT3 (d), ResT4 (e) and [FT3]/[FT4]
index(f) in male subjects. The line represents the linear regression fitted to the data points calculated by SPSS software.
Table 2 Spearman’s rank correlation coefficient between
age and various thyroid hormone indices
vs. Age male female
n = 735 n = 1721
Free T3 -0.292 (0.001>)** -0.033 (0.174)
Free T4 -0.170 (0.001>)** 0.014 (0.573)
TSH -0.042 (0.255) 0.138 (0.001>)**
log[TSH] 0.022(0.548) 0.099 (0.001>)**
ResT3 -0.194 (0.001>)** 0.061 (0.012)*
ResT4 -0.111 (0.003)** 0.106 (0.001>)**
FreeT3/FreeT4 -0.102 (0.006)** -0.025 (0.298)
Res: resistance index Parentheses show P-values. *P < 0.05, **P < 0.01.
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viously [16]. Benhadi et al. denoted the straight line as
the set point of the hypothalamus-pituitary-thyroid axis
[17]. The set point was probably affected by many fac-
tors, including genetic and environmental factors.
In this study, when we include the samples whose
TSH concentration is less than 0.04 μIU/ml, the value
of 2 S.D is larger than the mean value in free T4 con-
centration. Thus we omitted the samples whose TSH
concentration is less than 0.04 μIU/ml. There is no
mathematical reason why we omitted the samples whose
TSH concentration is over 9.99 μIU/ml. We should note
that subclinical hypothyroidism is associated with an
increased risk of cardiovascular disease events and mor-
tality in those with higher TSH levels, particularly in
those with TSH concentration of 10 μIU/ml or greater
[18].
In male subjects, negative relationships were observed
between aging and serum thyroid hormone concentra-
tion. TSH level was not altered by aging. Both resistance
indices were suppressed by aging. These data indicated
that the age-dependent lower FH concentrations do not
i n d u c eac o m p e n s a t o r yi n c r e a s ei nT S He x p r e s s i o ni n
males. There are two possible explanations for these
results. One is that age-dependent suppression of TSH
secretion is latently present, as described previously [1].
As a result, the lower serum hormone-induced TSH
expression may not overcome the suppressed TSH
secretion. The other possibility is that lower serum hor-
mone may be sufficient to suppress TSH secretion
because the resistance indices are suppressed. It is possi-
ble that males show age-dependent sensitization of thyr-
oid hormone action.
Aging did not affect the serum concentrations of free
thyroid hormones in female. The TSH levels increased
in an aging-dependent manner. Both resistance indices
increased significantly with age. These data indicated
that age-dependent thyroid hormone resistance in
females in contrast to the sensitization in males. The
ratio of [FT3] to [FT4] was reduced by aging in males
but not in females, suggesting that the deiodination
and/or transport of T4 were decreased in males.
The precise age distribution suggests that there are
three phases in the lifespan in terms of thyroid hormone
Figure 3 Relationships between age and the concentration of FT3 (a), FT4 (b), log[TSH] (c), ResT3 (d), ResT4 (e), and [FT3]/[FT4] index
(f) in female subjects. The line represents the linear regression fitted to the data points calculated using SPSS software.
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values of both indices were suppressed in male, suggest-
ing that some unknown factors may affect the response
to thyroid hormone in adolescent male. It is possible
that testosterone plays roles in regulation of response to
thyroid hormone, since free dihydrotestosterone concen-
tration peaks at the age group 20-25 [19]. The second
phase is the age between 25-64 years old. The mean
Figure 4 Age distributions of ResT3 (a), ResT4 (b), and [FT3]/[FT4] index (c) in males and females. The data represents the means ± S.E.o f
each age group. Bold and broken lines represent the values for males and females, respectively. Statistical significances show in Table 3.
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males aged between 25 - 34 and 55 - 64. There was,
h o w e v e r ,at e n d e n c yf o rt h er e s i s t a n c ei n d i c e st o
increase in the same 25 - 64 age groups, the pre-meno-
pausal phase in females. Many studies have suggested
that estrogen may overlap the thyroid hormone action
[20]. These data taken together indicate that age-depen-
dent depletion of estrogen may contribute to the pro-
gression of resistance to thyroid hormone action in
females.
The third phase is over 64 years old. The mean values
of the T3 resistance index were suppressed in males
over 64 years old, while that of the T4 index was not
significantly altered in both genders. The [FT3]/[FT4]
index was also decreased in males over 64, but not in
females, suggesting that the lack of a reduction in the
T4 index in males is probably due to the impaired con-
version of FT4 to FT3. In females, both resistance
indices were not increased although the reasons remain
unclear.
There are two limitations in this study. One is that the
subject is heterogeneous in terms of treatment.
Obviously, some patients may be administered supple-
mental T4 or anti-thyroid medication and/or radioiodine
therapy. These modifications may somehow affect thyr-
oid function, especially the conversion of FT4 to FT3.
These biases may affect the results of the [FT3]/[FT4]
index. Although we omitted the data from subjects with
extremely low TSH, we may not have excluded patients
with mild or moderate hypopituitarism. It is, however,
difficult to discriminate physiological hypopituitarism
from pathological disorders, as described previously [3].
We consider that age-related pituitary-thyroid regulation
may not be affected by pathological thyroid diseases,
since the accumulation of vulnerability with age is an all
around and non-specific process as described [21]. It is
assumed that serum thyroid hormone is the most potent
factor to regulate TSH level in all age groups. As both
FH and TSH concentrations were normal or mildly
abnormal range in the groups, TSH preferentially regu-
lates FH secretion vice versa at the time of sampling the
serum. Thus, the data selected in this study were likely
appropriate for assessment of negative feedback regula-
tion of thyroid hormone in aging.
Another issue is that the reflex indices in this study
may not precisely reflect the strength of the resistance
to thyroid hormone. Mathematically, there is a report
that log [TSH] is negatively proportional to the square
of free T4 concentration [22]. Since there is negative lin-
ear relationship between log [TSH] and free concentra-
tions, we conveniently added the two factors after
modification of the strength in this study.
Table 3 Statistical differences between each age group in male (upper area) and in female (lower area).
Age group 15-24 25-34 35-44 45-54 55-64 65-74 75-84
15-24 ResT3 0.001 > ** 0.003** 0.001 > ** 0.007** 0.001 > ** 0.001 > **
15-24 ResT4 0.011* 0.001** 0.001 > ** 0.002** 0.003** 0.189
15-24 FT3/FT4 0.866 0.998 0.441 0.839 0.007** 0.001 >
25-34 ResT3 0.999 0.639 1.0 0.508 0.920 0.358
25-34 ResT4 0.399 1.0 1.0 1.0 1.0 0.969
25-34 FT3/FT4 0.024* 0.557 0.999 0.218 0.251 0.001
35-44 ResT3 1.0 0.992 0.131 1.0 0.028* 0.017**
35-44 ResT4 1.0 0.668 1.0 1.0 1.0 0.914
35-44 FT3/FT4 1.0 0.031* 0.154 0.981 0.001** 0.001 > **
45-54 ResT3 0.778 0.922 0.649 0.072 0.857 0.282
45-54 ResT4 0.980 0.030* 0.875 1.0 1.0 0.764
45-54 FT3/FT4 0.787 0.416 0.796 0.046* 0.383 0.001 > **
55-64 ResT3 0.011* 0.013* 0.006** 0.331 0.016* 0.012*
55-64 ResT4 0.011* 0.001 > ** 0.004** 0.074 1.0 0.913
55-64 FT3/FT4 0.622 0.780 0.635 1.0 0.001 > ** 0.001 > **
65-74 ResT3 0.827 0.947 0.717 1.0 0.432 0.825
65-74 ResT4 0.175 0.001 > ** 0.083 0.541 0.985 0.939
65-74 FT3/FT4 0.997 0.006** 0.998 0.433 0.301 0.165
75-84 ResT3 0.995 0.959 0.998 0.715 0.102 0.738
75-84 ResT4 0.957 1.0 0.985 0.834 0.189 0.379
75-84 FT3/FT4 0.992 0.995 0.991 1.0 1.0 0.958
*P < 0.05, **P < 0.01.
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sensitization and resistance to thyroid hormone in males
and females, respectively. Due to the complexity of
negative feedback regulation, TSH level alone could not
be used to assess the thyroid hormone action in vivo.A s
TSH level is a convenient marker for assessment of
thyroid hormone action, it is necessary to exercise care
in interpretation of the values, especially on the basis of
age- and gender-related insights. The precise physiologi-
cal significance of gender-specific resistance to thyroid
hormone remains to be elucidated.
Abbreviations
FH: free hormone; FT3: free T3; FT4: free T4; ResT3: T3 resistance index;
ResT4:T4 resistance index.
Acknowledgements
This research was supported by a Grant-in -Aid for Scientific Research
(23591349) from Japan Society for the Promotion of Science.
Authors’ contributions
SN collected and summarized the data obtained from individual patients. TT
and MK contributed to discussion and edited the manuscript. SS conceived
of the experimental design, analyzed data and wrote the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 14 October 2011 Accepted: 26 January 2012
Published: 26 January 2012
References
1. Over R, Mannan S, Nsouli-Marktabi H, Burman KD, Jonklaas J: Age and the
thyrotropin response to hypothyroxinemia. J Clin Endocrinol Metab 2010,
95:3675-3683.
2. Mazzoccoli G, Pazienza V, Piepoli A, Muscarella LA, Inglese M, De Cata A,
Giuliani F, Tarquini R: Hypothalamus-hypophysis-thyroid axis function in
healthy aging. J Biol Regul Homeost Agents 2010, 24:433-439.
3. Sell MA, Schott M, Tharandt L, Cissewski K, Scherbaum WA, Willenberg HS:
Functional central hypothyroidism in the elderly. Aging Clin Exp Res 2008,
20:207-210.
4. Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, Magri F:
Neuroendocrine features in extreme longevity. Exp Gerontol 2008,
43:88-94.
5. Rozing MP, Houwing-Duistermaat JJ, Siagboom PE, Beekman M, Frolich M,
de Craen AJ, Westendorp RG, van Heemst D: Familial longevity is
associated with decreased thyroid function. J Clin Endocrinol Metab 2010,
95:4979-4984.
6. Alzmon G, Barzilai N, Surks MI, Gabriely I: Genetic predisposition to
elevated serum thyrotropin is associated with exceptional longevity. J
Clin Endocrinol Metab 2009, 94:4768-4775.
7. Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I: Extreme longevity
is associated with increased serum thyrotropin. J Clin Endocrinol Metab
2009, 94:1251-12544.
8. Surks MI, Hollowell JG: Age-specific distribution of serum thyrotropin and
antithyroid antibodies in the US population: implications for the
prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007,
92:4575-4582.
9. Roelfsema F, Pereira AM, Veldhuis JD, Adriaanse R, Endert E, Fliers E,
Romijn JA: Thyrotropin secretion profiles are not different in men and
women. J Clin Endocrinol Metab 2009, 94:3964-3967.
10. Hennemann G, Vos RA, de Jong M, Krenning EP, Docter R: Decreased
peripheral 3,5,3’-triiodothyronine (T3) production from thyroxine (T4): a
syndrome of impaired thyroid hormone activation due to transport
inhibition of T4- into T3-producing tissues. J Clin Endocrinol Metab 1993,
77:1431-1435.
11. Friesema EC, Visser WE, Visser TJ: Genetics and phenomics of thyroid
hormone transport by MCT8. Mol Cell Endocrinol 2010, 322:107-113.
12. Suzuki S, Mori J, Hashizume K: μ-crystallin, a NADPH-dependent T3-
binding protein in cytosol. Trends Endocrinol Metab 2007, 18:286-289.
13. Amaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG,
Setsu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L,
Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A,
Mariotti S, Shuldlner AR, Cao A, Schlessinger D, Uda M, Abecasis GR,
Nagaraja R, Sanna S, Naitza S: Phosphodiesterase 8B gene variants are
associated with serum TSH levels and thyroid function. Am J Hum Genet
2008, 82:1270-1280.
14. Perissi V, Jepsen K, Glass CK, Rosenfeld MG: Deconstructing repression:
evolving models of co-repressor action. Nat Rev Genet 2010, 11:109-123.
15. Hoermann R, Eckl W, Hoermann C, Larisch R: Complex relationship
between free thyroxine and TSH in the regulation of thyroid function.
Eur J Endocrinol 2010, 162:1123-1129.
16. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D,
Nicoloff JT: Applications of a new chemiluminometric thyrotropin assay
to subnormal measurement. J Clin Enodocrinol Metab 1990, 70:453-460.
17. Benhadi N, Filers E, Visser TJ, Reitsma JB, Wiersinga WM: Pilot study on the
assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in
healthy volunteers. Eur J Endocrinol 2010, 162:323-329.
18. Arking R: Measuring age-related changes in population. In Biology of
Aging.. 2 edition. Edited by: Sinauer AD. Sunderland: Sinauer Associates, Inc;
1998:27-59.
19. Stárka L, Pospisilová H, Hill M: Free testosterone and free
dihydrotestosterone throughout the life span of men. J Steroid Biochem
Mol Biol 2009, 116:118-120.
20. Davis PJ, Lin HY, Mousa SA, Luidens MK, Hercbergs AA, Wehling M,
Davis FB: Overlapping nongenomic actions of thyroid hormone and
steroids. Steroids 2011, 76:829-833.
21. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP,
Asvold BO, Lervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P,
Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA,
Westendrop RG, Vittinghoff E, Gussekloo J: Subclinical hypothyroidism and
the risk of coronary heart disease and mortality. JAMA 2010,
304:1365-1374.
22. Leow MK: A mathematical model of pituitary-thyroid interaction to
provide an insight into the nature of the thyrotorpin-thyroid hormone
relationship. J Theor Biol 2007, 248:275-287.
doi:10.1186/1756-6614-5-1
Cite this article as: Suzuki et al.: Gender-specific regulation of response
to thyroid hormone in aging. Thyroid Research 2012 5:1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Suzuki et al. Thyroid Research 2012, 5:1
http://www.thyroidresearchjournal.com/content/5/1/1
Page 8 of 8